Skip to main content
PMC home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2004 Jun 11;18(4):215–223. doi: 10.1002/jcla.20026

Technical and clinical evaluation of anti‐ribosomal P protein immunoassays

M Mahler 1,✉, K Kessenbrock 2, J Raats 3,5, MJ Fritzler 4
PMCID: PMC6807712  PMID: 15202113

Abstract

Autoantibodies to the three ribosomal phospho (‐P) proteins P0, P1, P2, referred to as Rib‐P, are specifically found in 10–40% of patients with systemic lupus erythematosus. The variations in the observed frequency of these autoantibodies is related to a number of factors such as the test system used to detect the antibodies. Several immunoassays that were designed for research and diagnostic laboratory use have been developed. The autoantigens employed in these tests include native proteins, recombinant polypeptides, and synthetic peptides. In this study, we compared the technical and clinical accuracy of anti‐Rib‐P antibody assays from different commercial suppliers including ELISA systems and a novel addressable laser bead assay (from Euroimmun, MBL, Pharmacia Diagnostics, INOVA). Although the assays from all suppliers used in this study performed well in the technical part of the study, relatively poor correlations and significant differences in the clinical accuracy were found. Based on the results, we conclude that the detection of anti‐Rib‐P antibodies strongly depends on both the nature of the antigen and the detection system. We recommend that anti‐Rib‐P assays should be standardized on an international level. The Varelisa® Rib‐P profile and the addressable laser bead Rib‐P assays represent promising tools and platforms for the detection of anti‐Rib‐P antibodies in the future. J. Clin. Lab. Anal. 18:215‐223, 2004. © 2004 Wiley‐Liss, Inc.

Keywords: autoantibody; SLE; Luminex; Rib‐P; ELISA, ribosome

REFERENCES

  • 1. Bonfa E, Golombek SJ, Kaufman LD, et al. Association between lupus psychosis and anti‐ribosomal P protein antibodies. N Engl J Med 1987;317:265–271. [DOI] [PubMed] [Google Scholar]
  • 2. Elkon K. Ribosomal RNP In: Van Venrooij WJ, Maini RN, editors. Manual of biological markers of disease. Dordrecht: Kluwer Academic Publishers; 1994. B2.5:1–11. [Google Scholar]
  • 3. Greenwood DL, Gitlits VM, Alderuccio F, Sentry JW, Toh BH. Autoantibodies in neuropsychiatric lupus. Autoimmunity 2002;35:79–86. [DOI] [PubMed] [Google Scholar]
  • 4. Hasler P, Brot N, Weissbach H, Parnassa AP, Elkon KB. Ribosomal proteins P0, P1, and P2 are phosphorylated by casein kinase II at their conserved carboxyl termini. J Biol Chem 1991;266:13815–13820 [PubMed] [Google Scholar]
  • 5. Mahler M, Kessenbrock K, Raats J, Williams R, Fritzler MJ, Bluthner M. Characterization of the human autoimmune response to the major C‐terminal epitope of the ribosomal P proteins. J Mol Med 2003;81:194–204. [DOI] [PubMed] [Google Scholar]
  • 6. Hasler P, Brot N, Weissbach H, et al. The effect of phosphorylation and site‐specific mutations in the immunodominant epitope of the human ribosomal P proteins. Clin Immunol Immunopathol 1994;72:273–279. [DOI] [PubMed] [Google Scholar]
  • 7. Teh LS, Lee MK, Wang F, et al. Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. Br J Rheumatol 1993;32:663–665. [DOI] [PubMed] [Google Scholar]
  • 8. Arnett FC, Reveille JD, Moutsopoulos HM, Georgescu L, Elkon KB. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum 1996;39:1833–1839. [DOI] [PubMed] [Google Scholar]
  • 9. Isenberg DA, Garton M, Reichlin MW, Reichlin M. Long‐term follow‐up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients. Br J Rheumatol 1997;136:229–233. [DOI] [PubMed] [Google Scholar]
  • 10. Ghirardello A, Caponi L, Franceschini F, et al. Diagnostic tests for antiribosomal P protein antibodies: a comparative evaluation of immunoblotting and ELISA assays. J Autoimmun 2002;19:71–77. [DOI] [PubMed] [Google Scholar]
  • 11. Bonfa E, Gaburo Junior N, Tavares AV, Cossermelli W. Comparison of five methods for the detection of antiribosomal P protein antibody. Braz J Med Biol Res 1994;27:637–643. [PubMed] [Google Scholar]
  • 12. Caponi L, Pegoraro S, Di Bartolo V, Rovero P, Revoltella R, Bombardieri S. Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA. J Immunol Methods 1995;179:193–202. [DOI] [PubMed] [Google Scholar]
  • 13. Yoshio T, Masuyama J, Ikeda M, et al. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus. J Rheumatol 1995;22:1681–1687. [PubMed] [Google Scholar]
  • 14. Rayno K, Reichlin M. Evaluation of assays for the detection of autoantibodies to the ribosomal P proteins. Clin Immunol 2000;95:99–103. [DOI] [PubMed] [Google Scholar]
  • 15. Sato T, Uchiumi T, Ozawa T, et al. Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease. J Rheumatol 1991;18:1681–1684. [PubMed] [Google Scholar]
  • 16. Martin AL, Reichlin M. Fluctuations of antibody to ribosomal P proteins correlate with appearance and remission of nephritis in SLE. Lupus 1996;5:22–29. [DOI] [PubMed] [Google Scholar]
  • 17. Reichlin M, Wolfson‐Reichlin M. Evidence for the participation of anti‐ribosomal P antibodies in lupus nephritis. Arthritis Rheum 1999;42:2728–2729. [DOI] [PubMed] [Google Scholar]
  • 18. Torre JC, Mozo L, Suarez A, Ramos E, Gutierrez C. Antibodies to ribosomal P proteins and hepatic damage in undifferentiated CTD. Ann Rheum Dis 1996;55:562–563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Schneebaum AB, Singleton JD, West SG, et al. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1991;90:54–62. [DOI] [PubMed] [Google Scholar]
  • 20. Reichlin M, Broyles TF, Hubscher O, et al. Prevalence of autoantibodies to ribosomal P proteins in juvenile‐onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum 1999;42:69–75. [DOI] [PubMed] [Google Scholar]
  • 21. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–1277. [DOI] [PubMed] [Google Scholar]
  • 22. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–324. [DOI] [PubMed] [Google Scholar]
  • 23. Tanimoto K, Nakano K, Kano S, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol 1995;22:668–674. [PubMed] [Google Scholar]
  • 24. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148–159. [DOI] [PubMed] [Google Scholar]
  • 25. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European community. Arthritis Rheum 1993;36:340–347. [DOI] [PubMed] [Google Scholar]
  • 26. Robinson WH, DiGennaro C, Hueber W, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002;8:295–301. [DOI] [PubMed] [Google Scholar]
  • 27. Robinson WH, Steinman L, Utz PJ. Proteomics technologies for the study of autoimmune disease. Arthritis Rheum 2002;46:885–893. [DOI] [PubMed] [Google Scholar]
  • 28. Fritzler MJ. New technologies in the detection of autoantibodies In: Conrad K, Fritzler MJ, Meurer M, Sack U, Shoenfeld Y, editors. Autoantigens, autoantibodies, autoimmunity. Lengerich: Pabst Scientific Publishers; p 50–63. [Google Scholar]
  • 29. Fritzler MJ, Wiik A, Fritzler ML, Barr SG. The use and abuse of autoantibody kits. Arthritis Res Ther 2003;5:192–201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Smolen JS, Butcher B, Fritzler MJ, et al. Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blotting. Arthritis Rheum 1997;40:413–418. [DOI] [PubMed] [Google Scholar]
  • 30. Elkon K, Bonfa E, Llovet R, Danho W, Weissbach H, Brot N. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens. Proc Natl Acad Sci U S A 1988;85:5186–5189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Nojima Y, Minota S, Yamada A, Takaku F, Aotsuka S, Yokohari R. Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1992;51:1053–1055. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES